Section "The Future of Clinical Trials: Organizational and Technological Shifts"

Today, a specialized section dedicated to key aspects of clinical trials and drug market access took place. The event was held in a businesslike and constructive atmosphere, bringing together leading industry experts. The meeting was moderated by Sergey Simeniv, founder and head of X7 Research. The focus was on issues of optimizing drug market access, digital transformation of clinical trials (CTs), and intelligent process automation.

Ekaterina Krasovskaya, MD, PhD, General Director of CRO "Vita Eterna" and "Serta Clinic" Medical Center, in her report "Optimizing Drug Market Access to the Russian and EAEU Markets," analyzed key barriers to registration and market access in Russia and EAEU countries, presented practical strategies for reducing drug launch timelines without compromising quality, shared real-world cases confirming the effectiveness of the chosen approaches, and identified promising directions for further improvement of regulatory procedures.

Yulia Novoselova, Head of Clinical Operations at GEROPHARM, in her report "Digital Transformation of Clinical Trials," highlighted the implementation of digital tools in clinical trial processes, discussed the advantages of electronic data capture and clinical trial management systems, shared the company's experience in using digital platforms to increase transparency and study speed, and presented an assessment of the impact of digitalization on data quality and regulatory compliance.

Tatiana Danilina, Product Manager at MELSIS (Medical Electronic Systems), in her report "Intelligent Automation for Clinical Trials: How the ClinNexus Platform Ensures Data Consistency and Accelerates the Medical Writer's Work," detailed the capabilities of the ClinNexus platform for integrating data from various sources, methods for ensuring data consistency and integrity during clinical trials, explained how routine task automation reduces report and documentation preparation time, and demonstrated the measurable effect of platform implementation using real project examples.

Victor Filin, General Director of Albion LLC, in his presentation on logistics for clinical trials, sparked lively interest from the audience. The speaker demonstrated how centralized travel management and the integration of logistics processes into the study protocol increase project efficiency.

The discussion was intense: participants asked speakers questions, discussed the nuances of implementing new approaches, and shared their own experiences.

We extend our sincere gratitude to all participants and speakers for their active engagement and valuable contribution to the substantive discussion of current issues.